Precision Biosciences (DTIL) Enterprise Value (2018 - 2026)
Precision Biosciences' (DTIL) quarterly Enterprise Value came in at -$28.3 million in Q1 2026, up 63.36% year-on-year from -$17.3 million in Q1 2025, and up 75.52% on a QoQ basis from -$115.6 million in Q4 2025.
Precision Biosciences (DTIL) Enterprise Value (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Enterprise Value data on file, last reported at -$28.3 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 63.36% year-over-year to -$28.3 million in Q1 2026; TTM through Mar 2026 was -$28.3 million, a 63.36% increase from a year earlier, with the FY2025 full-year figure at -$115.6 million, down 402.94% from the prior year.
- Enterprise Value for Q1 2026 stood at -$28.3 million, up from -$115.6 million in the prior quarter.
- Over the last five years, Enterprise Value for DTIL reached as high as -$22.6 million in Q2 2025 and fell as low as -$212.1 million in Q3 2022.
- Historically, Enterprise Value has averaged -$112.4 million across 5 years, with a median of -$116.7 million in 2023.
- On a YoY basis, Enterprise Value climbed as much as 81.74% in 2025 and fell as far as 402.94% in 2025.
- Year by year, Enterprise Value stood at -$189.6 million in 2022, then surged by 38.45% to -$116.7 million in 2023, then soared by 80.3% to -$23.0 million in 2024, then sank by 402.94% to -$115.6 million in 2025, then jumped by 75.52% to -$28.3 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$28.3 million in Q1 2026, -$115.6 million in Q4 2025, and -$44.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 472.06 Bn | 467.27 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 122.10 Bn | 114.85 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.25 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.50 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Precision Biosciences | 181.56 Mn | 153.26 Mn | - | -28.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.29 Mn |
| Dec 31, 2025 | -115.59 Mn |
| Sep 30, 2025 | -44.87 Mn |
| Jun 30, 2025 | -22.56 Mn |
| Mar 31, 2025 | -77.22 Mn |
| Dec 31, 2024 | -22.98 Mn |
| Sep 30, 2024 | -101.20 Mn |
| Jun 30, 2024 | -123.57 Mn |
| Mar 31, 2024 | -137.77 Mn |
| Dec 31, 2023 | -116.68 Mn |
| Sep 30, 2023 | -122.23 Mn |
| Jun 30, 2023 | -137.79 Mn |
| Mar 31, 2023 | -158.13 Mn |
| Dec 31, 2022 | -189.58 Mn |
| Sep 30, 2022 | -212.05 Mn |
| Jun 30, 2022 | -184.14 Mn |
| Mar 31, 2022 | -116.22 Mn |
| Dec 31, 2021 | -143.66 Mn |
| Sep 30, 2021 | -160.47 Mn |
| Jun 30, 2021 | -173.94 Mn |